Epidemiology Non-cholera Vibrio Infections

Completed

Brief Summary: The purpose of this study is to identify the epidemiological and clinical characteristics of patients diagnosed with non-cholera Vibrio infection in Western France from 2000 to 2019.

Detailed Description: Vibrios are gram-negative, ubiquitous bacteria of the marine flora and are found particularly in warm waters. For example, the incidence is high in Florida and Vibrio infections are now reportable in the United States. Different species of Vibrio are described. A distinction is made between choleric vibrios belonging to serogroups O1 and O139, responsible for cholera epidemics, and non-choleric vibrios. Our study will focus on non-cholera vibrios. Vibrio infections can occur by eating contaminated raw seafood or by exposure of a wound to the marine environment. They occur mainly during the hot summer months. This can be explained on the one hand by higher water temperature and on the other hand by increased beach use. With global warming, it is possible that Vibrio infections may increase in number and location.

Recruitment & Eligibility

Inclusion Criteria

Exclusion Criteria

Arm && Interventions

Group	Intervention	Description
non-cholera Vibrio infection	non-cholera Vibrio infection	Patients diagnosed with non-cholera Vibrio infection in Western France from 2000 to 2019

Primary Outcome Measures

Name	Time	Method
Number of Participants With Diagnosed Non-cholerae or Non-O1/O139 Vibrio Infection	Up to 20 years, from 2000-2019	A non-cholerae or non-O1/O139 Vibrio infection was defined by a biological sample (blood, superficial sample, deep sample, and ear sample) positive to a Vibrio species other than Vibrio cholerae O1-O139.

Secondary Outcome Measures

Name	Time	Method
Number of Participants Associated With Environmental Factors	at inclusion	environmental factors : seafood consumption, bathing/water activity, Injury in the aquatic environment, Walk to the beach, Handling of seafood products, returning from a trip abroad
Number of Participants Per Identified Species	at inclusion	Species: Vibrio alginolyticus, Vibrio cholerae Non-O1/Non-O139 Non toxinogenic, Vibrio parahaemolyticus, Vibrio vulnificus, Vibrio sp or other
Number of Participants by Month of the Years	at inclusion
Number of Participants Treated by Antibiotics	through study completion, an average of 1 month
Number of Patients Per Clinical History	at inclusion	Clinical history: diabetes, heart failure, hepatopathy, neoplasia, alcohol use disorder, Immunosuppressive drug, Pre-existing wound, Digestive surgery, Hemopathy, Kidney Disease
Number of Participants Per Outcome	through study completion, an average of 1 month	outcome :cure, cure with amputation, and deceased due to the infection

Locations (7): Centre Hospitalier Départemental de la Vendée
🇫🇷
La Roche-sur-Yon, France
CHU Nantes
🇫🇷
Nantes, France
CHU Angers
🇫🇷
Angers, France
CHU Bordeaux
🇫🇷
Bordeaux, France
CHU Poitiers
🇫🇷
Poitiers, France
CHU Rennes
🇫🇷
Rennes, France
CHU Tours
🇫🇷
Tours, France